| T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies (NCT00080925) | National Institutes of Health Clinical Center (CC) | 2004-02-01 |
| PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00093600) | Novartis Pharmaceuticals | 2004-02-01 |
| STA-5326 in Crohn's Disease Patients (NCT00088062) | Synta Pharmaceuticals Corp. | 2004-02-01 |
| Adoptive Immunotherapy for CMV Disease (NCT00159055) | Hadassah Medical Organization | 2004-02-01 |
| Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management (NCT00292110) | National Institute on Drug Abuse (NIDA) | 2004-02-01 |
| A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors (NCT02490475) | Hoffmann-La Roche | 2004-02-01 |
| Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors (NCT00096707) | Threshold Pharmaceuticals | 2004-02-01 |
| Immunotherapy of Stage III/IV Melanoma Patients (NCT00112242) | Centre Hospitalier Universitaire Vaudois | 2004-02-01 |
| Melatonin Postoperative Sleep Study in Breast Cancer Patients (NCT00506064) | M.D. Anderson Cancer Center | 2004-02-01 |
| Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers (NCT02259933) | Boehringer Ingelheim | 2004-02-01 |
| OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer (NCT00081237) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-02-01 |
| Study of the Safety and Immunogenicity of Bacille Calmette Guerin (BCG) Vaccine (NCT00654316) | University of Oxford | 2004-02-01 |
| Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94 (NCT00617032) | Targeted Genetics Corporation | 2004-02-01 |
| A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis (NCT00077870) | Genentech, Inc. | 2004-02-01 |
| A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants (NCT00322049) | U.S. Army Medical Research and Development Command | 2004-02-01 |
| Comparative Bioavailability Between Two Tramadol Formulations: Study of the Better Controlled Release of a New 200 mg Once A Day (OAD) Formulation Versus Zytram® 200 mg (NCT00911742) | Labopharm Inc. | 2004-02-01 |
| Bioavailability Study of Clonazepam Tablets Under Fasting Conditions (NCT00652639) | Par Pharmaceutical, Inc. | 2004-02-01 |
| Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma (NCT00327327) | AmpliMed Corporation | 2004-02-01 |
| TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) (NCT00077883) | Telik | 2004-02-01 |
| Early Breastfeeding Cessation - is It Possible to Prevent? (NCT00145834) | University of Aarhus | 2004-02-01 |
| Meloxicam 15 mg Tablets Under Fasting Conditions (NCT00840476) | Teva Pharmaceuticals USA | 2004-02-01 |
| Controlled Trial of Valacyclovir in Infectious Mononucleosis (NCT00274404) | University of Minnesota | 2004-02-01 |
| Photodynamic Therapy in Treating Patients With Lung Cancer (NCT01668823) | Roswell Park Cancer Institute | 2004-02-01 |
| Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia (NCT00078481) | National Institute of Neurological Disorders and Stroke (NINDS) | 2004-02-01 |
| Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00079378) | National Cancer Institute (NCI) | 2004-02-01 |
| Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg (NCT00647647) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| Meloxicam 15 mg Tablets Under Non-Fasting Conditions (NCT00840879) | Teva Pharmaceuticals USA | 2004-02-01 |
| Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors (NCT00080990) | National Cancer Institute (NCI) | 2004-02-01 |
| Project TAP: Tailored Activities Project (NCT00259467) | Thomas Jefferson University | 2004-02-01 |
| Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets (NCT01366352) | Bausch Health Americas, Inc. | 2004-02-01 |
| Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes (NCT01497600) | Novo Nordisk A/S | 2004-02-01 |
| Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men (NCT00431197) | Mayo Clinic | 2004-02-01 |
| Stretching Exercises and Temporomandibular Disorders (NCT00993577) | University of Sao Paulo General Hospital | 2004-02-01 |
| Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML (NCT00382954) | University of Kentucky | 2004-02-01 |
| Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers (NCT02253914) | Boehringer Ingelheim | 2004-02-01 |
| DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00077077) | Daiichi Sankyo | 2004-02-01 |
| Investigation How CG5503 is Taken up and Excreted From the Body After 2 Minutes Intravenous Infusion With and Without Oral Co-administration of Charcoal (NCT03951987) | Grünenthal GmbH | 2004-02-01 |
| Inspiratory Muscle Training in Ventilator Dependent Patients (NCT00419458) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2004-02-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00085488) | Dartmouth-Hitchcock Medical Center | 2004-02-01 |
| Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity (NCT02259751) | Boehringer Ingelheim | 2004-02-01 |
| Cilostazol 50 mg Tablets Under Fasting Conditions (NCT00839930) | Teva Pharmaceuticals USA | 2004-02-01 |
| Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093 (NCT02279667) | Bial - Portela C S.A. | 2004-02-01 |
| Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence (NCT01380132) | Uppsala University Hospital | 2004-02-01 |
| Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg (NCT00650195) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome (NCT00152100) | St. Jude Children's Research Hospital | 2004-02-01 |
| Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer (NCT00287963) | Medical University of South Carolina | 2004-02-01 |
| Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer (NCT00078494) | National Institutes of Health Clinical Center (CC) | 2004-02-01 |
| Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg (NCT00650234) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer (NCT00526461) | Roswell Park Cancer Institute | 2004-02-01 |
| TAIZ -Monocytes for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney) (NCT00223093) | University Hospital Schleswig-Holstein | 2004-02-01 |
| Usefulness of Integrative Medicine Tools As Adjunctive Care for Women After Coronary Artery Bypass Grafting (NCT01020227) | Columbia University | 2004-02-01 |
| Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524 (NCT00192478) | MedImmune LLC | 2004-02-01 |
| Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg (NCT00649948) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions (NCT00727272) | Mutual Pharmaceutical Company, Inc. | 2004-02-01 |
| Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg (NCT00648713) | Mylan Pharmaceuticals Inc | 2004-02-01 |
| MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. (NCT00147550) | Pfizer | 2004-02-01 |
| Pilot Trial of a Behavioral Treatment for Epilepsy (NCT00212745) | Oregon Health and Science University | 2004-02-01 |
| IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure (NCT00242788) | AstraZeneca | 2004-02-01 |
| Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer (NCT00681967) | AstraZeneca | 2004-02-01 |
| Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors (NCT00077454) | National Cancer Institute (NCI) | 2004-02-01 |
| Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes (NCT00075010) | M.D. Anderson Cancer Center | 2004-01-23 |
| Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation (NCT00052884) | Eastern Cooperative Oncology Group | 2004-01-22 |
| Letrozole Treatment in Normal and GnRH Deficient Women (NCT00351416) | Massachusetts General Hospital | 2004-01-21 |
| NM404 as an Imaging Agent in Patients With NSCLC (NCT00582283) | University of Wisconsin, Madison | 2004-01-14 |
| BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (NCT00077493) | MedImmune LLC | 2004-01-01 |
| To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions (NCT00881231) | Sandoz | 2004-01-01 |
| Transitional Treatment of Adolescents in Family Therapy (NCT00680381) | Oregon Research Institute | 2004-01-01 |
| 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors (NCT00079014) | National Cancer Institute (NCI) | 2004-01-01 |
| Topic Insulin Accelerates Wound Healing in Diabetes (NCT01295177) | University of Campinas, Brazil | 2004-01-01 |
| A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients (NCT00568698) | Stanford University | 2004-01-01 |
| Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients (NCT00129896) | Spanish Breast Cancer Research Group | 2004-01-01 |
| Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer (NCT00077519) | Abramson Cancer Center at Penn Medicine | 2004-01-01 |
| Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer (NCT00291785) | CTI BioPharma | 2004-01-01 |
| Study of the Enterprise Self-Expanding Stent System With Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms (NCT00233753) | Codman & Shurtleff | 2004-01-01 |
| A Modified Constraint-Induced Movement Therapy Program in Rehabilitation of Arm Paresis in Children With Cerebral Palsy (NCT00473447) | Universita di Verona | 2004-01-01 |
| Microglia Activation in Schizophrenia (NCT00205608) | Amsterdam UMC, location VUmc | 2004-01-01 |
| The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement (NCT00154518) | National Taiwan University Hospital | 2004-01-01 |
| Dose-Exposure-Response in Type 1 Diabetes Mellitus (NCT00368394) | Sanofi | 2004-01-01 |
| Minimum Dose CT Post Lung Biopsy (NCT00188162) | University Health Network, Toronto | 2004-01-01 |
| Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B (NCT00076557) | Avigen | 2004-01-01 |
| A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002) (NCT00990912) | Bristol-Myers Squibb | 2004-01-01 |
| The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1 (NCT00136747) | New York State Psychiatric Institute | 2004-01-01 |
| ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00471718) | Vanderbilt-Ingram Cancer Center | 2004-01-01 |
| Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects (NCT00310596) | Bayer | 2004-01-01 |
| Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases (NCT00185874) | Stanford University | 2004-01-01 |
| Once-daily Therapy for Streptococcal Pharyngitis (NCT01310361) | Azad University of Medical Sciences | 2004-01-01 |
| Age-Related Changes in Myosin Heavy Chain Composition in Human Orbicularis Oculi Muscle (NCT00154453) | National Taiwan University Hospital | 2004-01-01 |
| PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma (NCT00073892) | Cellxpert Biotechnology Corp. | 2004-01-01 |
| Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers (NCT02273531) | Boehringer Ingelheim | 2004-01-01 |
| Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects (NCT01289899) | Boryung Pharmaceutical Co., Ltd | 2004-01-01 |
| Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer (NCT00059865) | Alliance for Clinical Trials in Oncology | 2004-01-01 |
| Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors (NCT02225002) | Abramson Cancer Center at Penn Medicine | 2004-01-01 |
| Neoadjuvant/Adjuvant Chemotherapy, Vaccine & Adjuvant Radiation Therapy in p53-Overexpressing Stage III Breast Cancer (NCT00082641) | University of Nebraska | 2004-01-01 |
| The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy (NCT00228345) | University of Chicago | 2004-01-01 |
| GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00078962) | National Cancer Institute (NCI) | 2004-01-01 |
| University of Oklahoma Parenting Program Attrition (NCT00153465) | Centers for Disease Control and Prevention | 2004-01-01 |
| Diet and Behavior in Young Children With Autism (NCT00090428) | University of Rochester | 2004-01-01 |
| Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Men (NCT00121771) | London School of Hygiene and Tropical Medicine | 2004-01-01 |
| Gene Therapy for Chronic Granulomatous Disease (NCT00564759) | Johann Wolfgang Goethe University Hospital | 2004-01-01 |
| NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) (NCT01386619) | University Hospital, Basel, Switzerland | 2004-01-01 |